Regeneron Pharmaceuticals Inc. is a 32 MW Natural Gas Internal Combustion Engine asset in NYISO (New York), currently Standby.
Regeneron Pharmaceuticals Inc. is reported in New York since 2009 under Regeneron Pharmaceuticals Inc.. Available operating and financial measures include 1.1% capacity factor and 2 GWh annual generation; $765/kW reported CapEx.
- Location
- Westchester, New York
- Technology
- Natural Gas Internal Combustion Engine, Petroleum Liquids, Solar Photovoltaic
- Owner / parent
- Regeneron Pharmaceuticals Inc.
- Operator
- Regeneron Pharmaceuticals Inc.
- Grid
- NYISO (New York)
- Plant ID
- 62423
What stands out
Regeneron Pharmaceuticals Inc. is a 32 MW Natural Gas Internal Combustion Engine asset in New York with status Standby.
Latest annual operating measures report 1.1% capacity factor and 2 GWh annual generation.
Available financial measures include $765/kW CapEx.
Latest linked story: “Regeneron's Saratoga Springs project awarded $47M in incentives - Albany Business Review” (The Business Journals, 2025-12-17).
Market and operating context
- ISO / market
- NYISO (New York)
- Balancing authority
- New York Independent System Operator
- NERC region
- NPCC
- State rank
- #7 of 65
- National rank
- #100 of 825
Why it matters
For this asset in NYISO (New York), operating status, generation, ownership, and linked events are the primary facts for performance and asset-level diligence. The exact chart and source-linked records below let the reader test those facts before moving to a deeper report.
